506197 logo

Bliss GVS Pharma Limited Stock Price

BSE:506197 Community·₹55.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

506197 Share Price Performance

₹521.10
367.35 (238.93%)
₹521.10
367.35 (238.93%)
Price ₹521.10

506197 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with solid track record and pays a dividend.

2 Risks
1 Reward

Bliss GVS Pharma Limited Key Details

₹9.3b

Revenue

₹4.5b

Cost of Revenue

₹4.8b

Gross Profit

₹3.5b

Other Expenses

₹1.3b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
12.18
51.70%
13.93%
0.2%
View Full Analysis

About 506197

Founded
1984
Employees
1033
CEO
Shibroor Kamath
WebsiteView website
www.blissgvs.com

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Recent 506197 News & Updates

Recent updates

No updates